Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA-approved iPhone heart monitor now available

AliveCor's device can initially only be bought by US healthcare professionals

AliveCor iPhone heart monitorA device that transforms an iPhone into an FDA-approved heart monitor began shipping to US healthcare professionals this week.

AliveCor's Heart Monitor costs $199, requires a free app from the iTunes Store, and attaches to an iPhone in much the same way as many of the iPhone cases available.

Patients place their hands on the device's two built in sensors and it picks up and records electrocardiogram (ECG) rhythms, communicating the information wirelessly to the iPhone.

The company warns that the Heart Monitor is not meant to replace traditional 12-lead ECG machines, but says it will provide “quick, accurate rate and rhythm assessment”.

“At this time, AliveCor's Heart Monitor does not provide any diagnosis. A trained professional should read and diagnose any ECG rhythm data,” the San Francisco-based company said.

The device is initially only intended for use by healthcare professionals, although it wants to open up sales to the general public and international markets.

When AliveCor gained 510(K) Class II clearance from the FDA for the Heart Monitor in December 2012, the company's CEO Judy Wade told MobiHealthNews it will encourage doctors to prescribe the device to heart patients, potentially at a cost of $99.

The device's approval marks a big step forward for mobile health, although it will take time for AliveCor to make it more widely available.

The version that's on sale in the US is only approved for use with an iPhone 4 or 4S that's running iOS 5.1. The firm said it hopes to receive FDA approval for an iPhone 5 compatible version by the second quarter of this year.

AliveCor has been rather more coy about its plans for a tablet version but says an Android compatible device should be available in the third quarter, assuming it receives FDA backing.

10th January 2013

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Consulting

Impressive real world experience and expertise fused with process and fresh perspective to unlock opportunities for you, your brand and...

Latest intelligence

Free White Paper: Customer Experience for Pharma
To learn why an effective customer experience strategy is vital for pharma, download our white paper “Customer experience for pharma” to learn more....
How ethical is your brand plan? Introducing the hEQ.
Assess your brand plan’s Healthcare Ethics Quotient and see how these questions can give your brand plan a new perspective and engage your internal teams and external customers....
solution_options.png
Why e-detailing must give options to healthcare professionals
We know, we know. You want to talk about your treatment right away, but this really is an essential step that will make your e-detailing even more credible....